dr. powles on bevacizumab plus atezolizumab in kidney cancer
Published 7 years ago • 167 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
1:33
dr. powles on the impact of immunotherapy in kidney cancer
-
1:14
dr. mcgregor on the combination of atezolizumab and bevacizumab in rcc
-
1:41
dr. atkins on results of atezolizumab plus bevacizumab in rcc
-
0:46
dr. rini discusses atezolizumab plus bevacizumab in rcc
-
1:20
dr. van veldhuizen on the combination of atezolizumab and bevacizumab in kidney cancer
-
1:06
dr. choueiri on atezolizumab plus bevacizumab in non–clear cell rcc
-
2:05
dr. powles on potential for durvalumab in renal cancer
-
4:02
atezolizumab plus bevacizumab in non-clear cell, sarcomatoid kidney cancer
-
1:27
dr. rini on the tolerability of atezolizumab plus bevacizumab in rcc
-
4:25
kidney cancer updates: avelumab/axitinib, pembro/axitinib, bevacizumab/atezo & ipilimumab/nivo
-
1:34
dr. powles on rationale for keynote-426 in mrcc
-
1:03
dr. pishvaian discusses atezolizumab plus bevacizumab in hcc
-
3:44
atezolizumab bevacizumab in treatment-naïve mrcc
-
0:49
dr. kaseb on safety profile of atezolizumab plus bevacizumab in hcc
-
7:20
emerging immunotherapy combinations in kidney cancer
-
1:58
dr. atkins on excitement with atezolizumab and bevacizumab in rcc
-
1:50
dr. powles on the current state of research in bladder cancer
-
1:52
dr. powles on monitoring immunotherapy effects in patients with rcc
-
1:04
dr. lee on trial data evaluating the atezolizumab/bevacizumab in unresectable hcc